Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Stem Cell Therapeutics

This page shows the latest Stem Cell Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bayer helps bankroll new stem cell company BlueRock

Bayer helps bankroll new stem cell company BlueRock

Bayer helps bankroll new stem cell company BlueRock. Start-up receives $225m to develop cardiovascular and neurodegenerative disease therapies. ... There is a new player on the stem cell therapy stage, thanks to $225m in start-up funding from Bayer and

Latest news

  • Orphan status for Stem Cell's leukaemia drug Orphan status for Stem Cell's leukaemia drug

    US regulators have granted orphan drug status to tigecycline, a cancer drug in development by Stem Cell Therapeutics. ... Studies have demonstrated that the drug can target leukaemia cells by inhibiting certain proteins, however, influencing the Stem

  • ViaCyte appoints biotech veteran Paul Laikind as CEO

    ViaCyte appoints biotech veteran Paul Laikind as CEO. Will lead US firm's efforts to develop stem-cell therapy for people with diabetes. ... ViaCyte addresses one of the largest commercial and medical opportunities in stem-cell-derived therapeutics, and

  • The development of stem cell therapies The development of stem cell therapies

    In Europe, stem cell therapies are classified as 'advanced therapy medicinal products' (ATMPs). ... Other advances in the area of cardiovascular stem cell therapies include Cytori Therapeutics' adipose-derived stem and regenerative cells (ADRCs), which

  • UK regenerative medicine projects get £8.5m boost

    Novel stem cell manufacturing technologies. • Cell labelling and tracking technologies for quality control and monitoring in the body. • ... Regenerative medicine is an interdisciplinary approach that spans tissue engineering, developmental and stem

  • Survival strategy

    Licenser/Partner. Product/Technology. Development status. Headline ($m). Mesoblast/Cephalon. Stem cell therapeutics in CHF. ... Insulin producing beta cell regeneration. Preclinical. 349. Grunenthal/Gedeon Richter. Oral contraceptive range.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    Commercialisation. Oralair, grass allergy sublingual tablet (pre-registration). 120. Osiris Therapeutics / Mesoblast . ... Asset acquisition. Mesenchymal stem cell business, including Prochymal (approved). 100. † Hutchison MediPharma / Eli Lilly.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Quick links

Infographics

Multimedia